Cardiology

White Paper

Innovation and Partnerships: The Biotech Perspective

In the ever-evolving landscape of biotechnology, groundbreaking advancements continue to shape the future of healthcare. In this exclusive interview, Estelle Haenel, Chief Medical Officer at Kayentis, engages in a profound...

Case study

Cardiovascular case study: Global Phase III Study – Heart Failure & Actigraphy

Cardiology

After case studies about autoimmune & skin diseases, psoriasis and oncology, Kayentis releases its cardiovascular case study regarding heart failure and actigraphy....

Subscribe to our newsletter

Rare disease clinical research: it is time to tackle what...

The client’s voice: why they consistently choose Kayentis

Why you should join Kayentis

Rethinking pediatric clinical trials: guidelines from pediatric experts

Overcoming challenges in long-lasting pediatric clinical trials – Insights from...

Tackling the specificities of NASH/MASH clinical trials

About the author

Marc Chaperon

Estelle brings 20+ years of experience in pre-clinical and clinical research from Top 5 Pharma and Biotech firms. Leading projects across Phases 1 to 4 in diverse therapeutic areas, she offers deep insights into clinical science, operations, and regulatory intricacies. Appointed as Chief Medical Officer at Kayentis in May 2019.

Kayentis Europe
19 bis, chemin du vieux Chêne
38240 Meylan
France
Phone: +33 (0)4 76 00 54 20

Kayentis US
186 South Street
Suite 600
Boston, Massachusetts 02111
USA